Published in Rev Diabet Stud on November 10, 2009
The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes (2012) 0.94
C-Peptide and its intracellular signaling. Rev Diabet Stud (2009) 0.84
The beneficial effects of C-Peptide on diabetic polyneuropathy. Rev Diabet Stud (2009) 0.84
Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis. Shock (2014) 0.81
Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes. Am J Physiol Regul Integr Comp Physiol (2013) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med (1997) 7.65
Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care (2006) 5.25
Flow-induced release of endothelium-derived relaxing factor. Am J Physiol (1986) 3.51
The erythrocyte as a regulator of vascular tone. Am J Physiol (1995) 3.40
Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res (1992) 2.86
Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol (1998) 2.85
Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (1997) 2.31
ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol (1996) 2.23
Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature (1988) 2.07
Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension (1991) 1.77
Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun (1991) 1.64
Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med (2000) 1.63
The internal pH and membrane potential of the insulin-secretory granule. Biochem J (1982) 1.59
Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol (2001) 1.58
Conducted vascular responses: communication across the capillary bed. Microvasc Res (1998) 1.49
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.47
Addressing a vascular endothelium array with blood components using underlying microfluidic channels. Lab Chip (2007) 1.38
Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes (2006) 1.38
Arteriolar responses to extracellular ATP in striated muscle. Am J Physiol (1997) 1.34
Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol (2003) 1.33
C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes (2002) 1.32
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab (1993) 1.29
Receptor-mediated activation of the heterotrimeric G-protein Gs results in ATP release from erythrocytes. Med Sci Monit (2001) 1.18
Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) (2001) 1.16
The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia (1999) 1.14
An altered oxidant defense system in red blood cells affects their ability to release nitric oxide-stimulating ATP. Mol Biosyst (2006) 1.13
Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia (2007) 1.12
C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab (2004) 1.10
Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int (1998) 1.09
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest (1998) 1.08
Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int (2001) 1.06
C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J (2000) 1.05
EDRF generation and release from perfused bovine pulmonary artery and vein. Eur J Pharmacol (1988) 1.04
Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the vasculature: a new mechanism for nitrite-induced vasodilation. Am J Physiol Heart Circ Physiol (2009) 1.04
Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci (2006) 1.02
Interactions between multiple cell types in parallel microfluidic channels: monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug. Anal Chem (2008) 0.99
Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream. Anal Chem (2007) 0.99
Mechanisms of flow-mediated signal transduction in endothelial cells: kinetics of ATP surface concentrations. J Vasc Res (1993) 0.96
C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab (2006) 0.95
Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice. Am J Physiol Heart Circ Physiol (2004) 0.94
Effect of L-NAME on pressure-flow relationships in isolated rabbit lungs: role of red blood cells. Am J Physiol (1995) 0.92
Determination of erythrocyte deformability and its correlation to cellular ATP release using microbore tubing with diameters that approximate resistance vessels in vivo. Analyst (2003) 0.90
Measuring the simultaneous effects of hypoxia and deformation on ATP release from erythrocytes. Analyst (2008) 0.89
The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist. Integr Biol (Camb) (2009) 0.88
C-peptide exerts antithrombotic effects that are repressed by insulin in normal and diabetic mice. Diabetologia (2006) 0.84
C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab Res Rev (2007) 0.83
Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects. Thromb Res (2002) 0.82
Susceptibility of erythrocytes from non-insulin-dependent diabetes mellitus and hemodialysis patients, cigarette smokers and normal subjects to in vitro oxidative stress and loss of deformability. Clin Hemorheol Microcirc (2000) 0.82
C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am J Physiol Endocrinol Metab (2003) 0.82
Effects of C-peptide on expression of eNOS and iNOS in human cavernosal smooth muscle cells. Urology (2004) 0.79
C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res (2008) 0.79
Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin. Mol Biosyst (2009) 0.79
[Changes in erythrocyte deformability following changes in oxido-reductive metabolism in diabetes mellitus]. Ric Clin Lab (1983) 0.78
[The role of nonenzymatic glycation and glyco-oxidation in the development of diabetic vascular complications]. Cesk Fysiol (2003) 0.76
Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal Chem (2014) 2.53
A 3D printed fluidic device that enables integrated features. Anal Chem (2013) 1.45
3D printed microfluidic devices with integrated versatile and reusable electrodes. Lab Chip (2014) 1.43
Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest (2012) 1.41
Addressing a vascular endothelium array with blood components using underlying microfluidic channels. Lab Chip (2007) 1.38
Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol (2003) 1.33
Lateralization of circadian pacemaker output: Activation of left- and right-sided luteinizing hormone-releasing hormone neurons involves a neural rather than a humoral pathway. J Neurosci (2003) 1.20
Microfluidic technologies as platforms for performing quantitative cellular analyses in an in vitro environment. Analyst (2006) 1.20
Direct plate-reader measurement of nitric oxide released from hypoxic erythrocytes flowing through a microfluidic device. Anal Chem (2010) 1.09
Training with simulation improves residents' endovascular procedure skills. J Vasc Surg (2007) 1.05
Deformation-induced release of ATP from erythrocytes in a poly(dimethylsiloxane)-based microchip with channels that mimic resistance vessels. Anal Chem (2004) 1.05
3D-printed fluidic devices enable quantitative evaluation of blood components in modified storage solutions for use in transfusion medicine. Analyst (2014) 1.05
Integration of multiple components in polystyrene-based microfluidic devices part I: fabrication and characterization. Analyst (2012) 1.04
Fabrication of carbon microelectrodes with a micromolding technique and their use in microchip-based flow analyses. Analyst (2004) 1.01
Interactions between multiple cell types in parallel microfluidic channels: monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug. Anal Chem (2008) 0.99
Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream. Anal Chem (2007) 0.99
Simultaneous determination of cell aging and ATP release from erythrocytes and its implications in type 2 diabetes. Anal Chim Acta (2008) 0.97
Fluorescence monitoring of ATP-stimulated, endothelium-derived nitric oxide production in channels of a poly(dimethylsiloxane)-based microfluidic device. Anal Chem (2006) 0.97
Dynamic monitoring of glutathione in erythrocytes, without a separation step, in the presence of an oxidant insult. Anal Chem (2006) 0.95
Integration of multiple components in polystyrene-based microfluidic devices part II: cellular analysis. Analyst (2012) 0.92
Determination of erythrocyte deformability and its correlation to cellular ATP release using microbore tubing with diameters that approximate resistance vessels in vivo. Analyst (2003) 0.90
C-peptide and zinc delivery to erythrocytes requires the presence of albumin: implications in diabetes explored with a 3D-printed fluidic device. Integr Biol (Camb) (2015) 0.89
Measuring the simultaneous effects of hypoxia and deformation on ATP release from erythrocytes. Analyst (2008) 0.89
Microfluidic transendothelial electrical resistance measurement device that enables blood flow and postgrowth experiments. Anal Chem (2011) 0.89
Fabrication and evaluation of a 3-dimensional microchip device where carbon microelectrodes individually address channels in the separate fluidic layers. Analyst (2007) 0.88
The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist. Integr Biol (Camb) (2009) 0.88
Detection of ATP-induced nitric oxide in a biomimetic circulatory vessel containing an immobilized endothelium. Anal Chem (2003) 0.87
Evaluating the effects of estradiol on endothelial nitric oxide stimulated by erythrocyte-derived ATP using a microfluidic approach. Anal Bioanal Chem (2010) 0.86
Personalized metabolic assessment of erythrocytes using microfluidic delivery to an array of luminescent wells. Anal Chem (2009) 0.83
Using Per gene expression to search for photoperiodic oscillators in the hamster suprachiasmatic nucleus. Brain Res Mol Brain Res (2004) 0.83
Microfluidic evaluation of red cells collected and stored in modified processing solutions used in blood banking. Integr Biol (Camb) (2014) 0.82
Mass spectrometric characterization and activity of zinc-activated proinsulin C-peptide and C-peptide mutants. Analyst (2009) 0.81
Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts. J Cardiovasc Pharmacol Ther (2013) 0.80
Monitoring erythrocytes in a microchip channel that narrows uniformly: towards an improved microfluidic-based mimic of the microcirculation. J Chromatogr A (2005) 0.80
Microfluidic device with tunable post arrays and integrated electrodes for studying cellular release. Analyst (2014) 0.80
Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin. Mol Biosyst (2009) 0.79
Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production. Eur J Pharmacol (2010) 0.78
Conductance and stochastic switching of ligand-supported linear chains of metal atoms. Angew Chem Int Ed Engl (2006) 0.78
C-peptide-stimulated nitric oxide production in a cultured pulmonary artery endothelium is erythrocyte mediated and requires Zn(2+). Diabetes Metab Res Rev (2013) 0.78
Merging Microfluidics with Micro-titre Technology for More Efficient Drug Discovery. JALA Charlottesv Va (2008) 0.77
A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes. Analyst (2008) 0.76
Lineage-affiliated transcription factors bind the Gata3 Tce1 enhancer to mediate lineage-specific programs. J Clin Invest (2016) 0.76
Orbit and spin resolved magnetic properties of size selected [ConRh](+) and [ConAu](+) nanoalloy clusters. Phys Chem Chem Phys (2015) 0.75
Flow-based amperometric detection of dopamine in an immobilized cell reactor. J Neurosci Methods (2003) 0.75
Methotrexate-gelonin conjugate - an inhibitor of MCF-7 cells expressing the dihydrofolate receptor. Biol Chem (2014) 0.75
A public aid clinic prototype: utilizing a dental hygiene educational facility to increase access to care. J Dent Hyg (2003) 0.75